Literature DB >> 30660608

Checkpoint inhibitors in mesothelioma: hope for the future?

Anna Bibby1, Nick Maskell2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30660608     DOI： 10.1016/S1470-2045(18)30868-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma.

Authors:  Steven G Gray
Journal:  BMC Pulm Med       Date:  2021-05-05       Impact factor: 3.317

Review 2.  Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives.

Authors:  Steven G Gray; Luciano Mutti
Journal:  Transl Lung Cancer Res       Date:  2020-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.